DexCom, Inc. (NASDAQ:NASDAQ:DXCM) Q1 2022 Earnings Conference Call April 28, 2022 17:30 ET Company Participants Sean Christensen - Investor Relations Kevin Sayer - Chairman, President and.
Medpace Holdings (NASDAQ:MEDP) all have momentum and strong fundamentals on their side.
Dexcom, which makes wearable continuous glucose monitoring devices and the software for them, has the rise of the number of diabetes patients worldwide fueling its growth. CVS, known as a drug store company but firmly established as a medical insurer thanks to its purchase of Aetna, is helped by increased foot traffic in its stores as vaccination rates increase in the U.S. Medpace has benefited as companies turn to clinical research organizations to more seamlessly run their drug trials and approval processes for new medical therapies and devices.